Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

None of the other evaluated risk factors were genetically correlated with forearm fractures (Table 2 and Supplementary Note 4).Estimated genetic correlation between fractures and risk factors for fracturesrgPBMD-related parameters FN-BMD*−0.512.9 × 10−18 LS-BMD*−0.448.7 × 10−13 FA-BMD*−0.803.9 × 10−5 eBMD*−0.601.1 × 10−80Clinical risk factors Age at menopause−0.113.8 × 10−3 Age at menarche0.051.8 × 10−1 Relative age voice broke0.085.6 × 10−2 Grip strength0.033.0 × 10−1 Vitamin D levels0.075.5 × 10−3 Falls*0.241.8 × 10−12 Coronary artery disease−0.105.3 × 10−3 Rheumatoid arthritis0.009.8 × 10−1 Inflammatory bowel disease0.035.8 × 10−1 Type 2 diabetes−0.098.5 × 10−2 Ever versus never smoked−0.024.5 × 10−1 Alcohol consumption0.064.2 × 10−2 Height*0.091.4 × 10−3 BMI*−0.169.8 × 10−9We evaluated the genetic correlation (rg) for plausible risk factors for forearm fractures.

Source: Genetic correlations with risk factors for fractures. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We performed a GWAS discovery meta-analysis followed by a replication analysis for forearm fractures.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

An atlas of genetic determinants of forearm fracture

Review / evidence synthesis · Nature Genetics · 2023

Original publication title

An atlas of genetic determinants of forearm fracture

Maria Nethander; Sofia Movérare-Skrtic; Anders Kämpe; Eivind Coward; Ene Reimann; Louise Grahnemo; Éva Borbély; Zsuzsanna Helyes; Thomas Funck-Brentano; Martine Cohen-Solal; Juha Tuukkanen; Antti Koskela; Jianyao Wu; Lei Li; Tianyuan Lu; Maiken E. Gabrielsen; Estonian Biobank Research Team; Reedik Mägi; Mari Hoff; Ulf H. Lerner; Petra Henning; Henrik Ullum; Christian Erikstrup; Søren Brunak; DBDS Genomic Consortium; Arnulf Langhammer; Tiinamaija Tuomi; Asmundur Oddsson; Kari Stefansson; Ulrika Pettersson-Kymmer; Sisse Rye Ostrowski; Ole Birger Vesterager Pedersen; Unnur Styrkarsdottir; Outi Mäkitie; Kristian Hveem; J. Brent Richards; Claes Ohlsson

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Osteoporotic fracture is among the most common and costly of diseases. While reasonably heritable, its genetic determinants have remained elusive. Forearm fractures are the most common clinically recognized osteoporotic fractures with a relatively high heritability. To establish an atlas of the genetic determinants of forearm fractures, we performed genome-wide association analyses including 100,026 forearm fracture cases. We identified 43 loci, including 26 new fracture loci. Although most fracture loci associated with bone mineral density, we also identified loci that primarily regulate bone quality parameters.

Functional studies of one such locus, at TAC4, revealed that Tac4Not reported/Not reported mice have reduced mechanical bone strength. The strongest forearm fracture signal, at WNT16, displayed remarkable bone-site-specificity with no association with hip fractures. Tall stature and low body mass index were identified as new causal risk factors for fractures. The insights from this atlas may improve fracture prediction and enable therapeutic development to prevent fractures.

Genome-wide analyses identify 43 loci associated with forearm fracture, including some influencing bone quality parameters. Follow-up work shows that Tac4 knockout mice exhibit reduced mechanical bone strength with no effect on bone mineral density.

Authors’ abstract

Osteoporotic fracture is among the most common and costly of diseases. While reasonably heritable, its genetic determinants have remained elusive. Forearm fractures are the most common clinically recognized osteoporotic fractures with a relatively high heritability. To establish an atlas of the genetic determinants of forearm fractures, we performed genome-wide association analyses including 100,026 forearm fracture cases. We identified 43 loci, including 26 new fracture loci. Although most fracture loci associated with bone mineral density, we also identified loci that primarily regulate bone quality parameters.

Functional studies of one such locus, at TAC4, revealed that Tac4Not reported/Not reported mice have reduced mechanical bone strength. The strongest forearm fracture signal, at WNT16, displayed remarkable bone-site-specificity with no association with hip fractures. Tall stature and low body mass index were identified as new causal risk factors for fractures. The insights from this atlas may improve fracture prediction and enable therapeutic development to prevent fractures.

Genome-wide analyses identify 43 loci associated with forearm fracture, including some influencing bone quality parameters. Follow-up work shows that Tac4 knockout mice exhibit reduced mechanical bone strength with no effect on bone mineral density.

Publication and source details

Original title: An atlas of genetic determinants of forearm fracture

Maria Nethander; Sofia Movérare-Skrtic; Anders Kämpe; Eivind Coward; Ene Reimann; Louise Grahnemo; Éva Borbély; Zsuzsanna Helyes; Thomas Funck-Brentano; Martine Cohen-Solal; Juha Tuukkanen; Antti Koskela; Jianyao Wu; Lei Li; Tianyuan Lu; Maiken E. Gabrielsen; Estonian Biobank Research Team; Reedik Mägi; Mari Hoff; Ulf H. Lerner; Petra Henning; Henrik Ullum; Christian Erikstrup; Søren Brunak; DBDS Genomic Consortium; Arnulf Langhammer; Tiinamaija Tuomi; Asmundur Oddsson; Kari Stefansson; Ulrika Pettersson-Kymmer; Sisse Rye Ostrowski; Ole Birger Vesterager Pedersen; Unnur Styrkarsdottir; Outi Mäkitie; Kristian Hveem; J. Brent Richards; Claes Ohlsson

Nature Genetics · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.501100003849IngaBritt och Arne Lundbergs Forskningsstiftelse (Ingabritt and Arne Lundberg Research Foundation)LU2021-0096LU2017-0081501100009708Novo Nordisk Fonden (Novo Nordisk Foundation)NNF 190C0055250501100004063Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)KAW 2015.0317the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-720331 and ALFGBG-965235)the Hungarian Brain research Program 3.0, Hungarian National Research, Development and Innovation Office (OTKA K- 138046, OTKA FK-137951, TKP2021-EGA-16), New National Excellence Program of the Ministry for Innovation and Technology (ÚNKP-22-5-PTE-1447), János Bolyai János Scholarship (BO/00496/21/5) of the Hungarian Academy of Sciences, Eotvos Lorad Research Network, National Laboratory for Drug Research and Development.501100004359Vetenskapsrådet (Swedish Research Council)K20006-72X-20155013501100007687Svenska Läkaresällskapet (Swedish Society of Medicine)501100007067Kempestiftelserna (Kempe Foundations)JCK-1021the Swedish Sports Research Council (87/06) the Medical Faculty of Umeå University (ALFVLL:968:22-2005, ALFVLL: 937-2006, ALFVLL:223:11-2007, ALFVLL:78151-2009) the county council of Västerbotten (Spjutspetsanslag VLL:159:33-2007)

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T15:12:15.251554+00:00

DOI: 10.1038/s41588-023-01527-3 · PMC10632131